SCHEMBL9603271

SCHEMBL9603271

Cc1[nH]cnc1CCC1CCc2[nH]c3ccccc3c2C1=O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR3A P46098 4/20 0.38
HTR2C P28335 2/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
ADRA2C P18825 1/20 0.38
HTR2A P28223 1/20 0.38
ADRA1A P35348 1/20 0.38
HTR2B P41595 1/20 0.38
KCNH2 Q12809 1/20 0.38
CASP6 P55212 1/20 0.37
HTR3E A5X5Y0 2/20 0.36
HTR3B O95264 2/20 0.36
HTR3D Q70Z44 2/20 0.36
HTR3C Q8WXA8 2/20 0.36
TP53 P04637 1/20 0.35
HPGD P15428 1/20 0.35
HSD17B10 Q99714 1/20 0.35
SLC2A1 P11166 1/20 0.35
HRH2 P25021 1/20 0.34
HRH1 P35367 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9597484 0.89 HTR3A (0.39) HTR3AHTR2CCYP1A2CYP3A4ADRA2C
Maleic Acid SCHEMBL9597128 0.83 PADI4 (0.36) HTR3AHTR2CCYP1A2CYP3A4ADRA2C
Fumaric Acid SCHEMBL9597136 0.83 PADI4 (0.36) HTR3AHTR2CCYP1A2CYP3A4ADRA2C
SCHEMBL7408263 0.75 KMT2A (0.43) TP53HPGDHSD17B10SLC2A1
SCHEMBL23817260 0.74 NR2E1 (0.41) HTR2CCYP1A2TP53HPGDHSD17B10
SCHEMBL9366364 0.73 HTR3A (0.35) HTR3AHTR2CCYP1A2CYP3A4ADRA2C
SCHEMBL10343 0.72 CYP1A2 (0.63) HTR3AHTR2CCYP1A2CYP3A4ADRA2C
Iodide SCHEMBL7405172 0.72 HPGD (0.41) CYP1A2TP53HPGDHSD17B10SLC2A1
SCHEMBL9603272 0.72 HTR3A (0.36) HTR3AHTR2CCYP1A2CYP3A4ADRA2C
SCHEMBL3994101 0.72 CYP3A4 (0.62) HTR3ACYP1A2CYP3A4HTR2BKCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5202343-A Treating anxiety, psychological disorders GLAXO GROUP LIMITED (GB) 1993-04-13 US disclosed